Leonardo Viana Nicacio - 15 Apr 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Medical Officer
Signature
/s/ Leonardo Nicacio
Issuer symbol
TARA
Transactions as of
15 Apr 2025
Net transactions value
$0
Form type
4
Filing time
17 Apr 2025, 16:10:28 UTC
Next filing
21 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +50,000 +2293% $0.000000 52,181 15 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 15 Apr 2025 Common Stock 150,000 $4.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of April 15, 2025.
F2 25% of the shares vest on the one year anniversary of April 15, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.